XML 12 R4.htm IDEA: XBRL DOCUMENT v2.3.0.15
Condensed Consolidated Statements of Operations (unaudited) (USD $)
In Thousands, except Per Share data
3 Months Ended9 Months Ended
Oct. 02, 2011
Sep. 26, 2010
Oct. 02, 2011
Sep. 26, 2010
Condensed Consolidated Statements of Operations [Abstract]    
Revenues$ 36,006$ 50,812$ 108,017$ 120,928
Cost of products sold26,36735,68782,04386,958
Gross profit9,63915,12525,97433,970
Operating expenses:    
Research and development (including $77, $95, $234 and $314, respectively, of amortization of intangible assets)2,2942,5906,9156,180
Selling, general, and administrative (including $78, $79, $235 and $326, respectively, of amortization of intangible assets)5,7616,48418,73218,965
Total operating expenses8,0559,07425,64725,145
Operating income (loss)1,5846,0513278,825
Other income (expense):    
Interest income2 4 
Interest expense(126)(242)(444)(952)
Miscellaneous49436339353
Income (loss) from continuing operations before income taxes1,5096,2452268,226
Income tax provision-current66151133217
Income tax provision-deferred66130199224
Total income taxes132281332441
Net income (loss) from continuing operations1,3775,964(106)7,785
Discontinued operations:    
Loss from discontinued operations, net of tax (1,466)(3,796)(2,974)
Net income (loss)1,3774,498(3,902)4,811
Net (income) loss attributable to noncontrolling interest11283922
Net income (loss) attributable to Ultralife$ 1,388$ 4,526$ (3,863)$ 4,833
Net income (loss) attributable to Ultralife common shareholders - basic    
Continuing operations$ 0.08$ 0.35$ 0.00$ 0.45
Discontinued operations$ 0$ (0.09)$ (0.22)$ (0.17)
Total$ 0.08$ 0.26$ (0.22)$ 0.28
Net income (loss) attributable to Ultralife common shareholders - diluted    
Continuing operations$ 0.08$ 0.35$ 0.00$ 0.45
Discontinued operations$ 0$ (0.09)$ (0.22)$ (0.17)
Total$ 0.08$ 0.26$ (0.22)$ 0.28
Weighted average shares outstanding - basic17,31317,22517,29517,131
Weighted average shares outstanding - diluted17,34117,44917,29517,136